The Nerve Entrapment Syndrome Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The global market size for nerve entrapment syndrome has experienced a robust growth recently. The market size is projected to increase from $4.03 billion in 2024 to $4.34 billion in 2025, with a compound annual growth rate (CAGR) of 7.8%.
The Nerve Entrapment Syndrome Global Market is projected to grow to $5.77 billion in 2029, with a compound annual growth rate (CAGR) of 7.4%.
Download Your Free Sample of the 2025 Nerve Entrapment Syndrome Market Report and Uncover Key Trends Now!The key drivers in the nerve entrapment syndrome market are:
• Increase in the aging population
• Rising global incidence of peripheral nerve injuries
• Positive impact of government initiatives and reimbursement policies
• Increase in traumatic injuries and number of diabetic patients.
The nerve entrapment syndrome market covered in this report is segmented –
1) By Type: Carpal Tunnel Syndrome, Cubital Tunnel Syndrome, Tarsal Tunnel Syndrome, Meralgia Parasthetica, Other Types
2) By Treatment Modality: Medications, Physical Therapy, Interventional Procedures, Alteative Therapies
3) By Administration Route: Oral Administration, Injectable Administration, Topical Administration
4) By Severity Of Condition: Mild, Moderate, Severe, Post-Surgical Complications
Subsegments:
1) By Carpal Tunnel Syndrome (CTS): Idiopathic Carpal Tunnel Syndrome, Work-Related/Repetitive Strain CTS, Diabetic Neuropathy-Associated CTS, Traumatic or Post-Surgical CTS, Pregnancy-Induced CTS
2) By Cubital Tunnel Syndrome: Idiopathic Cubital Tunnel Syndrome, Repetitive Motion-Induced Cubital Tunnel Syndrome, Post-Traumatic/Ulnar Nerve Injury-Related Cubital Tunnel Syndrome, Osteoarthritis-Related Cubital Tunnel Syndrome, Post-Surgical Cubital Tunnel Syndrome
3) By Tarsal Tunnel Syndrome (TTS): Idiopathic Tarsal Tunnel Syndrome, Trauma-Induced Tarsal Tunnel Syndrome, Diabetes-Associated Tarsal Tunnel Syndrome, Flatfoot-Related Tarsal Tunnel Syndrome, Post-Surgical Or Scar Tissue-Related TTS
4) By Meralgia Paresthetica (MP): Idiopathic Meralgia Paresthetica, Obesity-Associated Meralgia Paresthetica, Pregnancy-Related Meralgia Paresthetica, Post-Surgical Or Scar-Induced Meralgia Paresthetica, Diabetic Neuropathy-Related Meralgia Paresthetica
5) By Other Types: Radial Tunnel Syndrome, Thoracic Outlet Syndrome, Peroneal Nerve Entrapment, Sciatic Nerve Entrapment, Brachial Plexus Compression Syndromes
The key trends in the nerve entrapment syndrome market are:
• Advancements in minimally invasive surgical procedures are leading trends.
• Increased traction in regenerative medicine research and procedures.
• Improved imaging techniques are becoming more prevalent in the market.
• There is growing innovation in physical therapy and rehabilitation, along with ongoing genetic research and personalized medicine.
Major players in the nerve entrapment syndrome market are:
• Pfizer Inc.
• Dr. Reddy’s Laboratories
• Glenmark Pharmaceuticals
• Athletico Physical Therapy
• Hinge Health
• Kessler Rehabilitation Center
• SPR Therapeutics
• Centaur Pharmaceuticals
• ProActive Physical Therapy & Rehabilitation
• Care24 Pvt Ltd.
• Grünenthal GmbH
• Total Performance Physical Therapy
• Back 2 Health
• Cornerstone Physical Therapy
• OrthoSport Physical Therapy & Rehabilitation
• Physio Tattva
• InvaGen Pharmaceuticals Inc.
• WEX Pharmaceuticals Inc.
• Dogwood Therapeutics Inc.
• Endo Spine Clinic
North America was the largest region in the nerve entrapment syndrome market in 2024